Numaferm x Labiotech – Podcast
For the “lazy” readers amongst us, a great chance to learn more about pepteins, how they are produced at Numaferm and how we help our […]
06 July 2023
Numaferm and Zoetis Sign License Agreement to Collaborate on Developing and Producing Proteins and Peptides
Numaferm, a Germany-based biotech company, specialized in the production of pepteins, and Zoetis, the global leading animal health company, have signed a licensing agreement for […]
25 May 2023
Numaferm @ BIO International Convention, Boston
Our CEO, Dr. Christian Schwarz and our Business Development Manager, Liv Kaser are looking forward to attend the BIO International Convention in Boston, taking place […]
22 May 2023
ISO 9001:2015 Re-Certification
After the successful TÜV audit, we have been re-certified, fulfilling all requirements according to DIN EN ISO 9001:2015.
10 May 2023
PolyPeptide and Numaferm announce partnership to leverage their expertise for the more sustainable production of peptide-based APIs
Baar (Switzerland) and Düsseldorf (Germany), 9 May 2023 – PolyPeptide, a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients (APIs), and Numaferm, a […]
08 March 2023
European Peptide Synthesis Conference
Liv Kaser, Business Development Manager at Numaferm (r) and Teresa Harris, Head of Marketing (l), attended and exhibited at the European Peptide Synthesis Conference in […]